In MDS, concentrations of S100A8 and S100A9 in bone marrow supernatant exhibit a positive correlation with advancing age, indicating a progressive intensification of age-associated inflammatory burden in the bone marrow [17]. Here, S100A9 is linked to myelodysplastic syndrome.